Go Ad-Free
My Alerts
Moneycontrol
Moneycontrol PRO
Get App Open
In App
Lending
Lending
Go PRO Now
Open App
MARKETS

Concord Biotech Ltd.

BSE: 543960 | NSE: CONCORDBIO |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE338H01029 | SECTOR: Biotechnology & Medical Research

| BSE 1366.60 -3.10 (-0.23%) | |

BSE Live

Dec 12, 11:52
1366.60 -3.10 (-0.23%)
Volume
AVERAGE VOLUME
5-Day
27,029
10-Day
14,499
30-Day
6,400
1,097

  • Prev. Close

    1369.70

  • Open Price

    1369.70

  • Bid Price (Qty.)

    1365.10 (14)

  • Offer Price (Qty.)

    1367.70 (12)

NSE Live

Dec 12, 11:52
1366.00 -4.20 (-0.31%)
Volume
AVERAGE VOLUME
5-Day
504,487
10-Day
280,124
30-Day
143,060
10,690

  • Prev. Close

    1370.20

  • Open Price

    1371.00

  • Bid Price (Qty.)

    1366.00 (64)

  • Offer Price (Qty.)

    1366.80 (22)

Financials

Cash Flow of Concord Biotech (in Rs. Cr.) Mar 25 Mar 24  
  12 mths 12 mths  
Net Profit/Loss Before Extraordinary Items And Tax 495.88 409.19  
Net CashFlow From Operating Activities 244.52 265.47  
Net Cash Used In Investing Activities -159.99 -154.61  
Net Cash Used From Financing Activities -98.77 -99.21  
Foreign Exchange Gains / Losses 0.00 0.00  
Adjustments On Amalgamation Merger Demerger Others 0.00 0.00  
Net Inc/Dec In Cash And Cash Equivalents -14.24 11.64  
Cash And Cash Equivalents Begin of Year 15.14 3.50  
Cash And Cash Equivalents End Of Year 0.90 15.14  
Source : Dion Global Solutions Limited

Results of Concord Biotech

  • 01.01.1970

  • 01.01.1970

Results of Biotechnology & Medical Research Sector

  • 01.01.1970

  • 01.01.1970

  • 01.01.1970

  • 01.01.1970

Quick links

News

Corporate Action

Information

Financials

Annual Report

Peer Comparison

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347